Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5879 posts found.

Cases of Bell’s Palsy linked to Sinovac’s COVID jab

August 17, 2021 Manufacturing and Production

A report recently published in The Lancet Infectious Diseases journal has found the risk of Bell’s Palsy, a type of …
News
novartis_window

Phase III trials for Novartis’s Beovu meet primary endpoints

August 17, 2021 Manufacturing and Production

Novartis has announced positive results from two Phase III clinical trials assessing Beovu in patients with diabetic macular edema. Year …
News

Biotage triples mRNA production equipment capacity

August 17, 2021 Manufacturing and Production

Biotage has announced the expansion of its production capacity of large-scale flash columns, an element important for the production of …
News

Moderna and Canada to collaborate on mRNA manufacturing

August 11, 2021 Manufacturing and Production, Research and Development

Moderna will build a messenger RNA (mRNA) vaccine manufacturing facility in Canada, which will include access to Moderna’s mRNA development …
News
gilead-sciences

Kite receives positive recommendation from SMC for CAR T therapy

August 10, 2021 Manufacturing and Production, Research and Development

Kite has announced a positive recommendation from the Scottish Medicines Consortium (SMC) on the company’s Healthcare Technology Assessment for Tecartus, …
News

AI system may be able to detect dementia in a day

August 10, 2021 Manufacturing and Production, Medical Communications, Research and Development

Researchers from Cambridge University and The Alan Turing Institute have developed an artificial intelligence (AI) system that can diagnose dementia …
News

Moderna could offer better defence against Delta variant than Pfizer

August 10, 2021 Manufacturing and Production

Pfizer-BioNTech’s mRNA could be less effective than Moderna’s against the Delta variant of COVID-19. In a study of more than …
News
pfizer_building_logo2_1

Scotland approves Merck and Pfizer’s Bavencio for bladder cancer

August 10, 2021 Manufacturing and Production

Merck and Pfizer’s Bavencio (avelumab) has been approved by approved by the Scottish Medicines Consortium (SMC) for use via NHS …
News

Novartis set to launch new Zolgensma trial to expand use

August 3, 2021 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Novartis has announced that it will launch a new Phase III study to expand the use of Zolgensma – the …
News

Cannabis-based oral spray could kill brain tumours, study to launch next year

August 3, 2021 Manufacturing and Production, Medical Communications, Research and Development

The NHS alongside cancer charities are set to launch a clinical trial to investigate the effects of a cannabis-based oral …
News
sanofi_hq__boetie_hall_small_

Sanofi to buy Translate Bio for $3.2 billion

August 3, 2021 Manufacturing and Production

Sanofi has agreed to buy U.S. biotech company Translate Bio in a $3.2 billion deal.This is part of Sanofi’s goal …
News
nice_new_london_office_internal_2_88

NICE approves UCB’s bimekizumab through expedited review process

August 3, 2021 Manufacturing and Production

NICE has published draft guidance on the first treatment to use its new review process, recommending UCB’s bimekizumab for treating …
News
fda_building_62

FDA approves AstraZeneca’s anifrolumab for treating lupus

August 3, 2021 Manufacturing and Production

The FDA has approved Saphnelo (anifrolumab) for the treatment of moderate-to-severe systemic lupus erythematosus (SLE), the most common form of …
News

CanSino’s inhaled COVID vaccine performs well in early trials

July 28, 2021 Manufacturing and Production, Research and Development

Early-stage data, published in The Lancet on Monday, has shown CanSino Biologic’s inhaled COVID-19 vaccine was able to stimulate neutralising …
News
astrazeneca_sign_sky

AstraZeneca & Regeneron to develop small molecule obesity treatment

July 28, 2021 Manufacturing and Production, Research and Development

AstraZeneca and Regeneron have announced a collaboration to research, develop and commercialise small molecule compounds directed against the GPR75 target …
News
The Gateway to Local Adoption Series

Latest content

Survodutide delivers up to 13.1% weight loss in phase 3 obesity and diabetes trial

October 6, 2026

ESTEVE CDMO adds $17.5m to Illinois expansion

October 6, 2026

AstraZeneca’s tozorakimab cuts COPD exacerbations by up to 34% in phase 3 trials

October 4, 2026

Brenntag and dsm-firmenich expand biopharma vitamin partnership

October 4, 2026

CeramTec expands German production capacity for orthopaedic ceramics

October 2, 2026